India · Delayed Price · Currency is INR Vivo Bio Tech Statistics
Total Valuation
Vivo Bio Tech has a market cap or net worth of INR 533.24 million. The enterprise value is 1.19 billion.
| Market Cap | 533.24M |
| Enterprise Value | 1.19B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivo Bio Tech has 22.19 million shares outstanding. The number of shares has increased by 36.28% in one year.
| Current Share Class | 22.19M |
| Shares Outstanding | 22.19M |
| Shares Change (YoY) | +36.28% |
| Shares Change (QoQ) | -8.08% |
| Owned by Insiders (%) | 12.89% |
| Owned by Institutions (%) | n/a |
| Float | 7.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1.53 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.24 |
| EV / EBITDA | 5.56 |
| EV / EBIT | 11.02 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.94 |
| Quick Ratio | 0.47 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 3.14 |
| Debt / FCF | -26.88 |
| Interest Coverage | 1.85 |
Financial Efficiency
Return on equity (ROE) is -2.00% and return on invested capital (ROIC) is -2.47%.
| Return on Equity (ROE) | -2.00% |
| Return on Assets (ROA) | 4.21% |
| Return on Invested Capital (ROIC) | -2.47% |
| Return on Capital Employed (ROCE) | 7.30% |
| Weighted Average Cost of Capital (WACC) | 1.08% |
| Revenue Per Employee | 3.07M |
| Profits Per Employee | -98,207 |
| Employee Count | 174 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.02 |
Taxes
In the past 12 months, Vivo Bio Tech has paid 65.19 million in taxes.
| Income Tax | 65.19M |
| Effective Tax Rate | 135.53% |
Stock Price Statistics
The stock price has decreased by -36.65% in the last 52 weeks. The beta is 0.38, so Vivo Bio Tech's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -36.65% |
| 50-Day Moving Average | 26.48 |
| 200-Day Moving Average | 30.08 |
| Relative Strength Index (RSI) | 41.64 |
| Average Volume (20 Days) | 69,664 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vivo Bio Tech had revenue of INR 533.35 million and -17.09 million in losses. Loss per share was -0.82.
| Revenue | 533.35M |
| Gross Profit | 452.08M |
| Operating Income | 108.22M |
| Pretax Income | 48.10M |
| Net Income | -17.09M |
| EBITDA | 214.49M |
| EBIT | 108.22M |
| Loss Per Share | -0.82 |
Balance Sheet
The company has 14.36 million in cash and 673.81 million in debt, with a net cash position of -659.45 million or -29.72 per share.
| Cash & Cash Equivalents | 14.36M |
| Total Debt | 673.81M |
| Net Cash | -659.45M |
| Net Cash Per Share | -29.72 |
| Equity (Book Value) | 931.58M |
| Book Value Per Share | 45.47 |
| Working Capital | -18.16M |
Cash Flow
In the last 12 months, operating cash flow was 349.31 million and capital expenditures -374.38 million, giving a free cash flow of -25.07 million.
| Operating Cash Flow | 349.31M |
| Capital Expenditures | -374.38M |
| Depreciation & Amortization | 106.27M |
| Net Borrowing | 116.72M |
| Free Cash Flow | -25.07M |
| FCF Per Share | -1.13 |
Margins
Gross margin is 84.76%, with operating and profit margins of 20.29% and -3.20%.
| Gross Margin | 84.76% |
| Operating Margin | 20.29% |
| Pretax Margin | 9.02% |
| Profit Margin | -3.20% |
| EBITDA Margin | 40.22% |
| EBIT Margin | 20.29% |
| FCF Margin | n/a |
Dividends & Yields
Vivo Bio Tech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.28% |
| Shareholder Yield | -36.28% |
| Earnings Yield | -3.20% |
| FCF Yield | -4.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 7, 2005. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 7, 2005 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |